Silk fibroin biomaterials for controlled release drug delivery
- 30 March 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 8 (6), 797-811
- https://doi.org/10.1517/17425247.2011.568936
Abstract
Introduction: Given the benefits of polymer drug delivery implants over traditional periodic systemic administration, the development of biomaterial systems with the necessary properties (biocompatibility, degradation, stabilization, controllability) is paramount. Silk fibroin represents a promising, naturally derived polymer for local, controlled, sustained drug release from fully degrading implants and the polymer can be processed into a broad array of material formats. Areas covered: This review provides an overview of silk biomaterials for drug delivery, especially those that can function as long-term depots. Fundamentals of structure and assembly, processing options, control points and specific examples of implantable silk drug delivery systems (sponges, films) and injectable systems (microspheres, hydrogels) from the 1990s and onwards are reviewed. Expert opinion: Owing to its unique material properties, stabilization effects and tight controllability, silk fibroin is a promising biomaterial for implantable and injectable drug delivery applications. Many promising control points have been identified, and characterization of the relationships between silk processing and/or material properties and the resulting drug loading and release kinetics will ultimately enhance the overall utility of this unique biomaterial. The ever-expanding biomaterial ‘tool kit’ that silk provides will eventually allow the simultaneous optimization of implant structure, material properties and drug release behavior that is needed to maximize the cost-efficiency, convenience, efficacy and safety of many new and existing therapeutics, especially those that cannot be delivered by means of traditional administration approaches.Keywords
This publication has 100 references indexed in Scilit:
- Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodiesBiomaterials, 2011
- Incorporation of proteinase inhibitors into silk-based delivery devices for enhanced control of degradation and drug releaseBiomaterials, 2011
- Silk-based delivery systems of bioactive moleculesAdvanced Drug Delivery Reviews, 2010
- Water-insoluble silk films with silk I structureActa Biomaterialia, 2010
- Electrospun silk biomaterial scaffolds for regenerative medicineAdvanced Drug Delivery Reviews, 2009
- Silk polymer-based adenosine release: Therapeutic potential for epilepsyBiomaterials, 2008
- In vivo degradation of three-dimensional silk fibroin scaffoldsBiomaterials, 2008
- Sonication-induced gelation of silk fibroin for cell encapsulationBiomaterials, 2008
- Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responsesBiomaterials, 2008
- Silk coatings on PLGA and alginate microspheres for protein deliveryBiomaterials, 2007